A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. - Cosden, Mali; Jinn, Sarah; Yao, Lihang; Gretzula, Cheryl A.; Kandebo, Monika; Toolan, Dawn; Hatcher, Nathan G.; Ma, Lei; Lemaire, Wei; Adam, Gregory C.; Burlein, Christine; Minnick, Christina; et al. (Neurobiology of Disease, 2021)